J P Morgan Chase & Co reaffirmed their neutral rating on shares of Sanofi SA (EPA:SAN) in a report released on Wednesday.

A number of other research firms also recently issued reports on SAN. Sanford C. Bernstein set a €91.00 ($105.81) target price on shares of Sanofi SA and gave the company a neutral rating in a research report on Tuesday, May 2nd. Deutsche Bank AG set a €96.00 ($111.63) target price on shares of Sanofi SA and gave the company a buy rating in a research report on Tuesday, May 2nd. Morgan Stanley set a €91.00 ($105.81) target price on shares of Sanofi SA and gave the company a buy rating in a research report on Tuesday, May 2nd. Goldman Sachs Group, Inc. (The) set a €82.00 ($95.35) target price on shares of Sanofi SA and gave the company a neutral rating in a research report on Tuesday, May 2nd. Finally, S&P Global set a €90.00 ($104.65) target price on shares of Sanofi SA and gave the company a neutral rating in a research report on Friday, April 28th. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and five have assigned a buy rating to the company. The company currently has an average rating of Hold and an average price target of €88.00 ($102.33).

Shares of Sanofi SA (SAN) opened at 81.59 on Wednesday. The firm has a market capitalization of €103.03 billion and a price-to-earnings ratio of 11.29. The company’s 50 day moving average is €25.48 and its 200-day moving average is €25.74. Sanofi SA has a one year low of €62.50 and a one year high of €92.97.

TRADEMARK VIOLATION WARNING: “J P Morgan Chase & Co Reiterates Neutral Rating for Sanofi SA (SAN)” was reported by Watch List News and is the property of of Watch List News. If you are accessing this story on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this story can be read at https://www.watchlistnews.com/j-p-morgan-chase-co-reiterates-neutral-rating-for-sanofi-sa-san/1461895.html.

Sanofi SA Company Profile

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company’s segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company’s pharmaceuticals operations.

Analyst Recommendations for Sanofi SA (EPA:SAN)

Receive News & Ratings for Sanofi SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi SA and related companies with Analyst Ratings Network's FREE daily email newsletter.